Furthermore, previous studies by our group have indicated a high expression of CXCR4, JUNB, and PD-L1 in CTCs and/or DTCs of breast cancer and NSCLC patients, related to their survival [29,30,31]. Here, CXCR4 is linked to breast cancer.